Chia-I Shen

发表

Utility of Cerebrospinal Fluid Cell-Free DNA in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer with Leptomeningeal Metastasis

T. Chou, C. Chiu, Yuh-Min Chen, 2021, Targeted Oncology.

Epidermal growth factor receptor mutations in non–small cell lung cancer undetected by high-sensitivity allele-specific real-time polymerase chain reaction–based assays

T. Chou, C. Chiu, Y. Yeh, 2020, Journal of the Chinese Medical Association : JCMA.

Post-Progression Survival in Secondary EGFR T790M-Mutated Non-Small-Cell Lung Cancer Patients With and Without Osimertinib After Failure of a Previous EGFR TKI

C. Chiu, Yuh-Min Chen, C. Chiang, 2020, Targeted Oncology.

Cytology–Based Specimen Triage for Epidermal Growth Factor Receptor Mutation Testing of Malignant Pleural Effusions in Non–Small Cell Lung Cancer

C. Chiu, Han Chang, C. Chiang, 2022, Frontiers in Oncology.

State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan

S. Chiou, Yuh-Min Chen, Mong-Lien Wang, 2022, International journal of molecular sciences.

EGFR mutant status and tyrosine-kinase inhibitors affect the GKRS outcomes for NSCLC brain metastases

Cheng-Chia Lee, Wan-Yuo Guo, Hsiu-Mei Wu, 2022, Journal of Neuro-Oncology.

Prognostic factors for advanced lung cancer patients with do-not-intubate order in intensive care unit: a retrospective study

Kuang-Yao Yang, Wei-Chih Chen, Chia-I Shen, 2022, BMC Pulmonary Medicine.

EGFR mutant status and tyrosine-kinase inhibitors affect the GKRS outcomes for NSCLC brain metastases

Ching-Jen Chen, Cheng-Chia Lee, Wan-Yuo Guo, 2022, Journal of Neuro-Oncology.

Effects of different brain surveillance strategies on outcomes for patients with EGFR-mutant metastatic lung adenocarcinoma under targeted therapy.

C. Chiu, C. Chiang, Hsu-Ching Huang, 2019, Lung cancer.

Progressive Pleural Effusion as an Immune-Related Adverse Event in NSCLC: A Case Report

C. Chiu, Y. Yeh, Chia-I Shen, 2021, JTO clinical and research reports.